Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: J Neuroendocrinol. 2013 Dec;25(12):1290–1297. doi: 10.1111/jne.12102

Figure 5. NPW siRNA pretreatment attenuated Ang II-induced increases in MAP.

Figure 5

Data represent area under curve (AUC) at 5 and 15 minutes post-injection. Data were analysed using a Mann-Whitney U test (**p<0.01, ***p<0.001, versus eGFP siRNA/saline; b: p<0.01 versus eGFP siRNA/50 pmol Ang II).